Cite
A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.
MLA
Suzuki, Junya, et al. “A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.” Biomedicines, vol. 11, no. 5, Apr. 2023. EBSCOhost, https://doi.org/10.3390/biomedicines11051295.
APA
Suzuki, J., Kaji, K., Nishimura, N., Kubo, T., Tomooka, F., Shibamoto, A., Iwai, S., Tsuji, Y., Fujinaga, Y., Kitagawa, K., Namisaki, T., Akahane, T., & Yoshiji, H. (2023). A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines, 11(5). https://doi.org/10.3390/biomedicines11051295
Chicago
Suzuki, Junya, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, et al. 2023. “A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation.” Biomedicines 11 (5). doi:10.3390/biomedicines11051295.